Immunology/Inflammation


The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-
A1052 alpha-1 antitrypsin fragment 235-243 [Homo sapiens]/[Papio hamadryas]/[Cercopithecus aethiops]Summary: Protease inhibitor -
A1053 amyloid A protein fragment [Homo sapiens]Summary: Apolipoproteins related to HDL in plasma -
B8362 2'3'-cGAMP (sodium salt)25 CitationSummary: STING agonist -
C6373 Dantrolene (sodium hemiheptahydrate)Summary: A noncompetitive inhibitor of glutathione reductase and the calcium channel RyR -
C6385 Loxoprofen SodiumSummary: A nonselective COX inhibitor with oral activity, exhibiting antipyretic, analgesic and anti-inflammatory effects -
C6391 Betahistine mesylateSummary: An orally active H1 receptor agonist and H3 receptor antagonist -
C6393 Erythromycin estolateSummary: An antibiotic for bacterial infection and cholestatic liver injury mechanisms -
C6397 Hydroxyzine pamoateSummary: A histamine H1 receptor antagonist for the treatment of chronic urticaria and allergic rhinitis -
C6401 Chloropyramine hydrochlorideSummary: A histamine H1 receptor antagonist with antiallergic and antitumor applications -
C6408 Diclofenac EpolamineSummary: A nonsteroidal anti-inflammatory drug with transdermal analgesic and anti-inflammatory effects

